# Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin

> **NCT02516085** · PHASE1 · COMPLETED · sponsor: **University Hospital, Basel, Switzerland** · enrollment: 5 (actual)

## Conditions studied

- Duchenne Muscular Dystrophy

## Interventions

- **DRUG:** Metformin
- **DRUG:** L-Arginine

## Key facts

- **NCT ID:** NCT02516085
- **Lead sponsor:** University Hospital, Basel, Switzerland
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-10
- **Final completion:** 2012-10
- **Target enrollment:** 5 (ACTUAL)
- **Last updated:** 2015-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02516085

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02516085, "Improved Muscle Function in Duchenne Muscular Dystrophy Through L-Arginine and Metformin". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02516085. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*